Literature DB >> 25242135

Novel DNA methylation targets in oral rinse samples predict survival of patients with oral squamous cell carcinoma.

Scott M Langevin1, Rondi A Butler2, Melissa Eliot2, Michael Pawlita3, Jennifer Z J Maccani4, Michael D McClean5, Karl T Kelsey6.   

Abstract

OBJECTIVES: The objective of this study was to identify novel survival-associated biomarkers in oral rinse samples collected from patients with oral squamous cell carcinoma (OSCC).
MATERIALS AND METHODS: We screened for putative survival-associated markers using publicly available methylation array data from 88 OSCC tumors. Cox models were then fit to methylation array data restricted to these putative loci in oral rinse samples of 82 OSCC patients from greater Boston. Pyrosequencing assays were designed for each locus that replicated in the oral rinse samples and applied to a validation set of oral rinse samples from another 61 OSCC patients.
RESULTS: We identified 7 survival-associated methylation markers in oral rinse samples from OSCC patients, and have validated one, located in the body of GABBR1, by pyrosequencing.
CONCLUSION: The 7 CpG loci identified through this study represent novel prognostic biomarkers for patients with OSCC that can be detected using a non-invasive oral rinse collection technique.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epigenomics; GABBR1; Mouthwash; Oral cancer; Prognosis

Mesh:

Year:  2014        PMID: 25242135      PMCID: PMC4254027          DOI: 10.1016/j.oraloncology.2014.08.015

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  48 in total

1.  Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma.

Authors:  Sara Duarte-Pereira; Filipa Paiva; Vera Lúcia Costa; João Ramalho-Carvalho; Joana Savva-Bordalo; Angelo Rodrigues; Franclim Ricardo Ribeiro; Vitor M Silva; Jorge Oliveira; Rui Henrique; Carmen Jerónimo
Journal:  Eur J Cancer       Date:  2011-01-25       Impact factor: 9.162

Review 2.  Kinesins and cancer.

Authors:  Oliver Rath; Frank Kozielski
Journal:  Nat Rev Cancer       Date:  2012-07-24       Impact factor: 60.716

Review 3.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

Authors:  Boudewijn J M Braakhuis; Maarten P Tabor; J Alain Kummer; C René Leemans; Ruud H Brakenhoff
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

4.  Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3.

Authors:  Ka-Po Tse; Wen-Hui Su; Kai-Ping Chang; Ngan-Ming Tsang; Chia-Jung Yu; Petrus Tang; Lee-Chu See; Chuen Hsueh; Min-Lee Yang; Sheng-Po Hao; Hong-Yi Li; Ming-Hsi Wang; Li-Ping Liao; Lih-Chyang Chen; Sheue-Rong Lin; Timothy J Jorgensen; Yu-Sun Chang; Yin Yao Shugart
Journal:  Am J Hum Genet       Date:  2009-08-06       Impact factor: 11.025

5.  Human GABA(B)R genomic structure: evidence for splice variants in GABA(B)R1 but not GABA(B)R2.

Authors:  S C Martin; S J Russek; D H Farb
Journal:  Gene       Date:  2001-10-31       Impact factor: 3.688

6.  Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma.

Authors:  Satoshi Nagata; Tomofumi Hamada; Norishige Yamada; Seiya Yokoyama; Sho Kitamoto; Yuji Kanmura; Masahiro Nomura; Yoshiaki Kamikawa; Suguru Yonezawa; Kazumasa Sugihara
Journal:  Cancer       Date:  2012-01-17       Impact factor: 6.860

7.  Two populations of double minute chromosomes harbor distinct amplicons, the MYC locus at 8q24.2 and a 0.43-Mb region at 14q24.1, in the SW613-S human carcinoma cell line.

Authors:  M Guillaud-Bataille; O Brison; G Danglot; C Lavialle; B Raynal; V Lazar; P Dessen; A Bernheim
Journal:  Cytogenet Genome Res       Date:  2009-04-14       Impact factor: 1.636

8.  EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions.

Authors:  Juliana Schussel; Xian Chong Zhou; Zhe Zhang; Kavita Pattani; Francisco Bermudez; Germain Jean-Charles; Thomas McCaffrey; Tapan Padhya; Joan Phelan; Silvia Spivakovsky; Mariana Brait; Ryan Li; Helen Yoo Bowne; Judith D Goldberg; Linda Rolnitzky; Miriam Robbins; A Ross Kerr; David Sirois; Joseph A Califano
Journal:  Clin Cancer Res       Date:  2013-05-01       Impact factor: 12.531

9.  Identification of genes with allelic imbalance on 6p associated with nasopharyngeal carcinoma in southern Chinese.

Authors:  Yan Li; Li Fu; Alissa Michelle Go Wong; Yan-Hui Fan; Miao-Xin Li; Jin-Xin Bei; Wei-Hua Jia; Yi-Xin Zeng; Danny Chan; Kenneth M C Cheung; Pak Sham; Daniel Chua; Xin-Yuan Guan; You-Qiang Song
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

10.  CpG-island methylation study of liver fluke-related cholangiocarcinoma.

Authors:  R Sriraksa; C Zeller; M A El-Bahrawy; W Dai; J Daduang; P Jearanaikoon; S Chau-In; R Brown; T Limpaiboon
Journal:  Br J Cancer       Date:  2011-03-29       Impact factor: 7.640

View more
  14 in total

1.  Stability of methylation markers in head and neck squamous cell carcinoma.

Authors:  Shama Virani; Emily Light; Lisa A Peterson; Maureen A Sartor; Jeremy M G Taylor; Jonathan B McHugh; Gregory T Wolf; Laura S Rozek
Journal:  Head Neck       Date:  2015-11-13       Impact factor: 3.147

2.  Portrait of DNA methylated genes predictive of poor prognosis in head and neck cancer and the implication for targeted therapy.

Authors:  Jessica Hier; Olivia Vachon; Allison Bernstein; Iman Ibrahim; Alex Mlynarek; Michael Hier; Moulay A Alaoui-Jamali; Mariana Maschietto; Sabrina Daniela da Silva
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

3.  NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas.

Authors:  Shama Virani; Emily Bellile; Carol R Bradford; Thomas E Carey; Douglas B Chepeha; Justin A Colacino; Joseph I Helman; Jonathan B McHugh; Lisa A Peterson; Maureen A Sartor; Jeremy Mg Taylor; Heather M Walline; Greg T Wolf; Laura S Rozek
Journal:  BMC Cancer       Date:  2015-10-30       Impact factor: 4.430

Review 4.  Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.

Authors:  Rogerio M Castilho; Cristiane H Squarize; Luciana O Almeida
Journal:  Int J Mol Sci       Date:  2017-07-12       Impact factor: 5.923

5.  Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).

Authors:  Soo Yeon Kim; Yu Kyeong Han; Jae Min Song; Chang Hun Lee; Keunsoo Kang; Joo Mi Yi; Hae Ryoun Park
Journal:  Clin Epigenetics       Date:  2019-08-12       Impact factor: 6.551

Review 6.  Epigenetics: A possible answer to the undeciphered etiopathogenesis and behavior of oral lesions.

Authors:  Narendra Nath Singh; Aakanksha Peer; Sherin Nair; Rupesh K Chaturvedi
Journal:  J Oral Maxillofac Pathol       Date:  2016 Jan-Apr

7.  CpG island methylation profile in non-invasive oral rinse samples is predictive of oral and pharyngeal carcinoma.

Authors:  Scott M Langevin; Melissa Eliot; Rondi A Butler; Agnes Cheong; Xiang Zhang; Michael D McClean; Devin C Koestler; Karl T Kelsey
Journal:  Clin Epigenetics       Date:  2015-12-03       Impact factor: 6.551

8.  Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.

Authors:  David C Christiani; Sipeng Shen; Guanrong Wang; Qianwen Shi; Ruyang Zhang; Yang Zhao; Yongyue Wei; Feng Chen
Journal:  Clin Epigenetics       Date:  2017-08-24       Impact factor: 6.551

9.  Identification of DNA methylation prognostic signature of acute myelocytic leukemia.

Authors:  Haiguo Zhang; Guanli Song; Guanbo Song; Ruolei Li; Min Gao; Ling Ye; Chengfang Zhang
Journal:  PLoS One       Date:  2018-06-22       Impact factor: 3.240

10.  Differences in the prognosis of gastric cancer patients of different sexes and races and the molecular mechanisms involved.

Authors:  Huafu Li; Chunming Wang; Zhewei Wei; Wei Chen; Zicong Guo; Yulong He; Changhua Zhang
Journal:  Int J Oncol       Date:  2019-09-26       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.